Innovent Biologics Shares Rally on New Eli Lilly Oncology and Immunology Deal 
Once Upon a Farm Raises Nearly $198 Million in IPO, Valued at Over $724 Million 
Taiwan Says Moving 40% of Semiconductor Production to the U.S. Is Impossible 
SpaceX Pivots Toward Moon City as Musk Reframes Long-Term Space Vision 
Trump Backs Nexstar–Tegna Merger Amid Shifting U.S. Media Landscape 
Indian Refiners Scale Back Russian Oil Imports as U.S.-India Trade Deal Advances 
American Airlines CEO to Meet Pilots Union Amid Storm Response and Financial Concerns 
Alphabet Plans Rare 100-Year Sterling Bond to Fund AI Expansion 
Anta Sports Expands Global Footprint With Strategic Puma Stake 
Washington Post Publisher Will Lewis Steps Down After Layoffs 
Hims & Hers Halts Compounded Semaglutide Pill After FDA Warning 
Salesforce Workforce Reduction Affects Fewer Than 1,000 Roles Amid Ongoing Restructuring 
American Airlines CEO to Meet Pilots Union Amid Storm Response and Financial Concerns 
Treasury Wine Estates Shares Surge After U.S. Dispute Settlement and Earnings Upgrade 
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing 
DBS Expects Slight Dip in 2026 Net Profit After Q4 Earnings Miss on Lower Interest Margins 
Kroger Set to Name Former Walmart Executive Greg Foran as Next CEO 
Dublin, Dec. 13, 2017 -- The "DNA Sequencing - Technologies, Markets and Companies" report from Jain PharmaBiotech has been added to Research and Markets' offering.
This report reviews basics of human genome variations, development of sequencing technologies, and their applications. Current large and small sequencers are described as well as companies developing them. Various applications of sequencing are described including those for genetics, medical diagnostics, drug discovery and cancer. Next generation sequencing technologies, both second and third generations, are reviewed. Companies developing software for analysis of sequencing data are also included. Selected academic institutes conducting research in sequencing are also listed.
Current market is mostly for research applications and future markets will be other applications related to healthcare. The value of DNA sequencer market in 2016 is described with estimates for 2021 and 2026. Various methods and factors on which market estimates depend are described briefly. Markets are tabulated according to geographical areas as well as applications. Small sequencers form the basis of SWOT (strengths, weaknesses, opportunities, threats) analysis. Several marketing strategies have been outlined.
The report includes profiles of 138 companies involved in sequencing and their 147 collaborations. The report text is supplementd by 42 tables, 23 figures and 500 selected references to the literature.
Key Topics Covered:
Executive Summary
1. Introduction
2. DNA Sequencing Technologies
3. Role of Bioinformatics in Sequencing
4. Comparative Analysis of Sequencing Technologies
5. Sequencing for Research
6. Applications of Sequencing in Healthcare
7. Applications of Sequencing in Oncology
8. Sequencing in Genetic Disorders
9. Sequencing in Neurological and Psychiatric Disorders
10. Applications of sequencings in infections
11. Role of Sequencing in Personalized Medicine
12. Current Status and Future Prospects
13. Markets for Sequencers
14. Companies Involved in Sequencing
For more information about this report visit https://www.researchandmarkets.com/research/zthc3d/dna_sequencing?w=12
CONTACT: Research and Markets
Laura Wood, Senior Manager
[email protected]
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Genomics
